FDA Accepts BLA for Shanghai Henlius Biotech’s HLX11, a Pertuzumab Biosimilar
Teva and mAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership
Update on Recent International Biosimilar Approvals
GSK Sues Pfizer for Patent Infringement over RSV Vaccine
Fresenius Kabi Launches STIMUFEND (pegfilgrastim-fpgk) in the United States
Fresenius Kabi Announces FDA Approval of Adalimumab Biosimilar
Biogen Announces EMA Acceptance of Tocilizumab Biosimilar Application
Teva Receives Approval for First Ophthalmology Biosimilar in Europe
Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologics
Subscribe: Subscribe via RSS
Blogs
Firm/Org